These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 22554766

  • 21. Cisplatin encapsulated in phosphatidylethanolamine liposomes enhances the in vitro cytotoxicity and in vivo intratumor drug accumulation against melanomas.
    Hwang TL, Lee WR, Hua SC, Fang JY.
    J Dermatol Sci; 2007 Apr; 46(1):11-20. PubMed ID: 17267180
    [Abstract] [Full Text] [Related]

  • 22. Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity.
    Jung SH, Jung SH, Seong H, Cho SH, Jeong KS, Shin BC.
    Int J Pharm; 2009 Dec 01; 382(1-2):254-61. PubMed ID: 19666094
    [Abstract] [Full Text] [Related]

  • 23. Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration.
    Abu Lila AS, Nawata K, Shimizu T, Ishida T, Kiwada H.
    Int J Pharm; 2013 Nov 01; 456(1):235-42. PubMed ID: 23928149
    [Abstract] [Full Text] [Related]

  • 24. Polymeric micelles incorporating (1,2-diaminocyclohexane)platinum (II) suppress the growth of orthotopic scirrhous gastric tumors and their lymph node metastasis.
    Rafi M, Cabral H, Kano MR, Mi P, Iwata C, Yashiro M, Hirakawa K, Miyazono K, Nishiyama N, Kataoka K.
    J Control Release; 2012 Apr 30; 159(2):189-96. PubMed ID: 22326402
    [Abstract] [Full Text] [Related]

  • 25. Liposomal topotecan formulation with a low polyethylene glycol grafting density: pharmacokinetics and antitumour activity.
    Li C, Wang C, Yang H, Zhao X, Wei N, Cui J.
    J Pharm Pharmacol; 2012 Mar 30; 64(3):372-82. PubMed ID: 22309269
    [Abstract] [Full Text] [Related]

  • 26. In vivo anti-tumor effect of PEG liposomal doxorubicin (DOX) in DOX-resistant tumor-bearing mice: Involvement of cytotoxic effect on vascular endothelial cells.
    Ogawara K, Un K, Tanaka K, Higaki K, Kimura T.
    J Control Release; 2009 Jan 05; 133(1):4-10. PubMed ID: 18840484
    [Abstract] [Full Text] [Related]

  • 27. Sterically stabilized anti-G(M3), anti-Le(x) immunoliposomes: targeting to B16BL6, HRT-18 cancer cells.
    Nam SM, Kim HS, Ahn WS, Park YS.
    Oncol Res; 1999 Jan 05; 11(1):9-16. PubMed ID: 10451027
    [Abstract] [Full Text] [Related]

  • 28. Effects of PEG-liposomal oxaliplatin on apoptosis, and expression of Cyclin A and Cyclin D1 in colorectal cancer cells.
    Yang C, Liu HZ, Fu ZX.
    Oncol Rep; 2012 Sep 05; 28(3):1006-12. PubMed ID: 22710431
    [Abstract] [Full Text] [Related]

  • 29. Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide.
    Chen X, Wang X, Wang Y, Yang L, Hu J, Xiao W, Fu A, Cai L, Li X, Ye X, Liu Y, Wu W, Shao X, Mao Y, Wei Y, Chen L.
    J Control Release; 2010 Jul 01; 145(1):17-25. PubMed ID: 20307599
    [Abstract] [Full Text] [Related]

  • 30. Combination therapy of metronomic S-1 dosing with oxaliplatin-containing polyethylene glycol-coated liposome improves antitumor activity in a murine colorectal tumor model.
    Doi Y, Okada T, Matsumoto H, Ichihara M, Ishida T, Kiwada H.
    Cancer Sci; 2010 Nov 01; 101(11):2470-5. PubMed ID: 20731663
    [Abstract] [Full Text] [Related]

  • 31. Intratumor distribution of doxorubicin following i.v. administration of drug encapsulated in egg phosphatidylcholine/cholesterol liposomes.
    Harasym TO, Cullis PR, Bally MB.
    Cancer Chemother Pharmacol; 1997 Nov 01; 40(4):309-17. PubMed ID: 9225948
    [Abstract] [Full Text] [Related]

  • 32. PEG-liposomal oxaliplatin combined with nuclear factor-κB inhibitor (PDTC) induces apoptosis in human colorectal cancer cells.
    Yang C, Fu ZX.
    Oncol Rep; 2014 Oct 01; 32(4):1617-21. PubMed ID: 25174808
    [Abstract] [Full Text] [Related]

  • 33. Development of liposomes entrapped in alginate beads for the treatment of colorectal cancer.
    Bansal D, Gulbake A, Tiwari J, Jain SK.
    Int J Biol Macromol; 2016 Jan 01; 82():687-95. PubMed ID: 26464131
    [Abstract] [Full Text] [Related]

  • 34. Co-administration of liposomal l-OHP and PEGylated TS shRNA-lipoplex: A novel approach to enhance anti-tumor efficacy and reduce the immunogenic response to RNAi molecules.
    Alaaeldin E, Abu Lila AS, Ando H, Fukushima M, Huang CL, Wada H, Sarhan HA, Khaled KA, Ishida T.
    J Control Release; 2017 Jun 10; 255():210-217. PubMed ID: 28461099
    [Abstract] [Full Text] [Related]

  • 35. Targeted delivery of cargoes into a murine solid tumor by a cell-penetrating peptide and cleavable poly(ethylene glycol) comodified liposomal delivery system via systemic administration.
    Kuai R, Yuan W, Li W, Qin Y, Tang J, Yuan M, Fu L, Ran R, Zhang Z, He Q.
    Mol Pharm; 2011 Dec 05; 8(6):2151-61. PubMed ID: 21981683
    [Abstract] [Full Text] [Related]

  • 36. Oxystress inducing antitumor therapeutics via tumor-targeted delivery of PEG-conjugated D-amino acid oxidase.
    Fang J, Deng D, Nakamura H, Akuta T, Qin H, Iyer AK, Greish K, Maeda H.
    Int J Cancer; 2008 Mar 01; 122(5):1135-44. PubMed ID: 17990314
    [Abstract] [Full Text] [Related]

  • 37. Improvement of intratumor microdistribution of PEGylated liposome via tumor priming by metronomic S-1 dosing.
    Doi Y, Abu Lila AS, Matsumoto H, Okada T, Shimizu T, Ishida T.
    Int J Nanomedicine; 2016 Mar 01; 11():5573-5582. PubMed ID: 27822036
    [Abstract] [Full Text] [Related]

  • 38. Modulation of antitumor immunity contributes to the enhanced therapeutic efficacy of liposomal oxaliplatin in mouse model.
    Shimizu T, Abu Lila AS, Nishio M, Doi Y, Ando H, Ukawa M, Ishima Y, Ishida T.
    Cancer Sci; 2017 Sep 01; 108(9):1864-1869. PubMed ID: 28643902
    [Abstract] [Full Text] [Related]

  • 39. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).
    Maruyama K, Ishida O, Kasaoka S, Takizawa T, Utoguchi N, Shinohara A, Chiba M, Kobayashi H, Eriguchi M, Yanagie H.
    J Control Release; 2004 Aug 11; 98(2):195-207. PubMed ID: 15262412
    [Abstract] [Full Text] [Related]

  • 40. Ultrasound enhanced antitumor activity of liposomal doxorubicin in mice.
    Hagtvet E, Evjen TJ, Olsen DR, Fossheim SL, Nilssen EA.
    J Drug Target; 2011 Sep 11; 19(8):701-8. PubMed ID: 21524240
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.